Stockreport

Immunocore announces reimbursement agreement in England for KIMMTRAK? for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma

Immunocore Holdings plc - American Depositary Shares  (IMCR) 
PDF Immunocore announces reimbursement agreement in England for KIMMTRAK? for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma [Read more]